Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Amlodipine Besylate; Celecoxib Patent Expiration

Amlodipine Besylate; Celecoxib is Used for treating adult patients with hypertension and osteoarthritis. It was first introduced by Purple Biotech Ltd in its drug Consensi on May 31, 2018.


Amlodipine Besylate; Celecoxib Patents

Given below is the list of patents protecting Amlodipine Besylate; Celecoxib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Consensi US10350171 Celecoxib and amlodipine formulation and method of making the same Jun 14, 2038 Purple Biotech
Consensi US10925835 Celecoxib and amlodipine formulation and method of making the same Jun 14, 2038 Purple Biotech
Consensi US10945960 Celecoxib and amlodipine formulation and method of making the same Jun 14, 2038 Purple Biotech
Consensi US9408837 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs Feb 28, 2030 Purple Biotech
Consensi US9662315 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs May 22, 2029 Purple Biotech


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳